Cargando…

Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy

RASSF2 is a novel pro-apoptotic effector of K-Ras that is frequently inactivated in a variety of primary tumors by promoter methylation. Inactivation of RASSF2 enhances K-Ras-mediated transformation and overexpression of RASSF2 suppresses tumor cell growth. In this study, we confirm that RASSF2 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Jennifer, Freeman, Jessica, Donninger, Howard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368207/ https://www.ncbi.nlm.nih.gov/pubmed/22693671 http://dx.doi.org/10.1155/2012/705948

Ejemplares similares

RASSF1A and the Taxol Response in Ovarian Cancer
por: Kassler, Susannah, et al.
Publicado: (2012)

Proteomics Analysis Reveals Novel RASSF2 Interaction Partners
por: Barnoud, Thibaut, et al.
Publicado: (2016)

The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer
por: Harrell Stewart, Desmond R., et al.
Publicado: (2020)

RASSF1A and the rs2073498 Cancer Associated SNP
por: Donninger, Howard, et al.
Publicado: (2011)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Resistance to Targeted Therapy and RASSF1A Loss in Melanoma: What Are We Missing?
por: McKenna, Stephanie, et al.
Publicado: (2021)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras Status
por: Cao, Dan, et al.
Publicado: (2013)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015)

Identification and characterization of RASSF1C piRNA target genes in lung cancer cells
por: Reeves, Mark E, et al.
Publicado: (2017)

RASSF1A controls tissue stiffness and cancer stem‐like cells in lung adenocarcinoma
por: Pankova, Daniela, et al.
Publicado: (2019)

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling
por: Nelson, Nicholas, et al.
Publicado: (2016)

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers
por: Riffet, Marc, et al.
Publicado: (2021)

Methylation Dynamics of RASSF1A and Its Impact on Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2019)

Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors
por: Malpeli, Giorgio, et al.
Publicado: (2011)

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome
por: Chen, Tao, et al.
Publicado: (2017)

The Drosophila RASSF Homolog Antagonizes the Hippo Pathway
por: Polesello, Cedric, et al.
Publicado: (2006)

The Role of RASSF1C in the Tumor Microenvironment
por: Amaar, Yousef G., et al.
Publicado: (2023)

Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer
por: Xu, Weizhen, et al.
Publicado: (2015)

Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the Envelope
por: Li, Chi, et al.
Publicado: (2020)

The cellular functions of RASSF1A and its inactivation in prostate cancer
por: Amin, Karishma S., et al.
Publicado: (2012)

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010)

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis
por: Perez-Janices, Noemi, et al.
Publicado: (2015)

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours
por: Cooper, WN, et al.
Publicado: (2008)

Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy
por: Sun, Xicai, et al.
Publicado: (2017)

Cancer Vaccines: Promising Therapeutics or an Unattainable Dream
por: Donninger, Howard, et al.
Publicado: (2021)

The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma
por: Gao, Hong, et al.
Publicado: (2022)

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
por: Xu, Jia, et al.
Publicado: (2012)

RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?
por: Scrace, Simon F., et al.
Publicado: (2012)

Regulation of mitosis and taxane response by Daxx and Rassf1
por: Giovinazzi, Serena, et al.
Publicado: (2011)

Rassf Proteins as Modulators of Mst1 Kinase Activity
por: Bitra, Aruna, et al.
Publicado: (2017)

A porcine model system of BRCA1 driven breast cancer
por: Donninger, Howard, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6okuh0k4uj59ntkffj0sdor2tg